News
JBA AI has been officially recognized by the United States Food and Drug Administration (FDA) as a Software as a Medical ...
The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based ...
AI may provide an answer to the question of whether drugs initially developed and prescribed for non-neurodegenerative physical conditions can be used to treat individuals with Parkinson’s disease.
A former FDA reviewer offers advice to help innovative medtech avoid new and more dangerous pitfalls as experts leave the ...
7h
InsideHook on MSNResearchers Make the Case for More Regulation of Medical AIMore and more devices using AI and machine learning technology are becoming available for purchase, something that’s just as ...
Welcome to our live blog tracking the latest developments in Artificial Intelligence. Stay updated with real-time insights ...
Levelpath, the leading AI-native procurement platform, today announced breakthrough customer results that delightfully solve industry-wide AI struggles. Despite $34 billion invested in private ...
Santa Clara University's School of Engineering today announced the launch of a new interdisciplinary Master of Science in Artificial Intelligence (MSAI) program, designed to equip students with ...
16hon MSN
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” first quarter 2025 investor ...
The FDA announced last week it launched Elsa, an AI tool designed to help employees work better. AI also is impacting ...
Consumer tech is going through a drastic change, and most of it looks impressive. But why should it matter to you? Here's why.
BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript
In a call hosted today, June 9, 2025, PolyPid Ltd. unveiled highly successful topline results from its SHIELD II Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results